跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MAR-TOPIRAMATE
Authorized
STANDARD
MAR-TOPIRAMATE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1b4d49c513376f90
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
1b4d49c513376f90
Drug Approval Canada Name
MAR-TOPIRAMATE
Product Name
MAR-TOPIRAMATE
Status
Dormant
Status Date
2018-09-30
Original Market Date
2016-11-29
Din
02432102
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX11 TOPIRAMATE
Atc Name
n 03 ax 11
Aig Number
0132938002
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
TOPIRAMATE
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1b4d49c513376f90
Type
Standard
Back to Health Canada Approvals
MAR-TOPIRAMATE - Health Canada Drug Approval Details